# reload+after+2024-01-22 08:47:38.866811
address1§955 Chesterbrook Boulevard
address2§Suite 110
city§Chesterbrook
state§PA
zip§19087
country§United States
phone§610 354 8840
website§https://www.trevena.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania.
fullTimeEmployees§35
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Carrie L. Bourdow', 'age': 60, 'title': 'President, CEO & Chairman', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 1002005, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Barry  Shin', 'age': 51, 'title': 'Senior VP & CFO', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 670025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Mark A. Demitrack', 'age': 65, 'title': 'Senior VP & Chief Medical Officer', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 690316, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Howard A. Rockman M.D.', 'title': 'Scientific Founder, Consultant and Member of Scientific Advisory Board', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Joel  Solomon', 'title': 'VP, General Counsel & Chief Compliance Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Michael  Catalano', 'title': 'Vice President of Marketing', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Robert T. Yoder', 'age': 57, 'title': 'Senior VP, Chief Business Officer & Head of Commercial Operations', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 490639, 'exercisedValue': 0, 'unexercisedValue': 9545}, {'maxAge': 1, 'name': 'Ms. Patricia M. Drake', 'age': 57, 'title': 'Senior VP & Chief Commercial Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.745
priceToSalesTrailing12Months§3.3827949
currency§USD
dateShortInterest§1702598400
forwardEps§-0.87
exchange§NCM
quoteType§EQUITY
shortName§Trevena, Inc.
longName§Trevena, Inc.
firstTradeDateEpochUtc§1391178600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§ab31c962-bf5d-3c6b-b3ee-f6b5d965694f
gmtOffSetMilliseconds§-18000000
targetHighPrice§9.0
targetLowPrice§4.0
targetMeanPrice§6.5
targetMedianPrice§6.5
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§5.707
grossMargins§0.80792
ebitdaMargins§0.0
trailingPegRatio§None
